Magnet Biomedicine
Cambridge
About Magnet Biomedicine
Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues. Magnet Biomedicine leverages its TrueGlue discovery platform, which utilizes the latest advancements in human biology and proteomics. This platform identifies specialized adhesives optimized to maximize therapeutic effectiveness while delivering significant advantages, such as enhancing selectivity, fostering biological synergy on specific targets, and addressing previously challenging-to-target proteins. Magnet Biomedicine is actively harnessing the vast untapped potential of TrueGlues to address various disease areas and biological mechanisms, including but not limited to cancer, cardiovascular disease, and immune disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2023)
- Website: magnetbio.com
- Phone: 1 (617) 741-0974
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/magnet-biomedicine-35192 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.